Skip to Main content Skip to Navigation
Journal articles

A non-conserved amino acid variant regulates differential signalling between human and mouse CD28

Abstract : CD28 superagonistic antibodies (CD28SAb) can preferentially activate and expand immu-nosuppressive regulatory T cells (Treg) in mice. However, pre-clinical trials assessing CD28SAbs for the therapy of autoimmune diseases reveal severe systemic inflammatory response syndrome in humans, thereby implying the existence of distinct signalling abilities between human and mouse CD28. Here, we show that a single amino acid variant within the C-terminal proline-rich motif of human and mouse CD28 (P 212 in human vs. A 210 in mouse) regulates CD28-induced NF-κB activation and pro-inflammatory cytokine gene expression. Moreover, this Y 209 APP 212 sequence in humans is crucial for the association of CD28 with the Nck adaptor protein for actin cytoskeleton reorganisation events necessary for CD28 autonomous signalling. This study thus unveils different outcomes between human and mouse CD28 signalling to underscore the importance of species difference when transferring results from preclinical models to the bedside.
Document type :
Journal articles
Complete list of metadata

Cited literature [61 references]  Display  Hide  Download
Contributor : Jacques Nunès Connect in order to contact the contributor
Submitted on : Tuesday, January 7, 2020 - 3:22:38 PM
Last modification on : Thursday, September 9, 2021 - 9:38:07 AM


Publisher files allowed on an open archive


Distributed under a Creative Commons Attribution 4.0 International License




Nicla Porciello, Paola Grazioli, Antonio Campese, Martina Kunkl, Silvana Caristi, et al.. A non-conserved amino acid variant regulates differential signalling between human and mouse CD28. Nature Communications, Nature Publishing Group, 2018, 9 (1), pp.1080. ⟨10.1038/s41467-018-03385-8⟩. ⟨hal-01772994⟩



Record views


Files downloads